Antibe Therapeutics Inc.
ATE
Classement en actions
#31913
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Prix de l'action
$0.21483059
Dernière synchronisation: 2024-05-07
Capitalisation boursière
$11.13M
Changement (1 jour)
0.34%
Changement (1 an)
-0.36%
Pays
CA
Échange Antibe Therapeutics Inc. (ATE)
Catégorie
Healthcare
Capitalisation boursière de Antibe Therapeutics Inc.(ATE)
Capitalisation boursière: $11.13M
En October 2026, Antibe Therapeutics Inc. a une capitalisation boursière de $11.13M. Cela fait de Antibe Therapeutics Inc. la 31913th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Antibe Therapeutics Inc. du 2014 au 2026
ATE par rapport au top 5 des plus populaires stocks
| Prix pour ATE | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$97,474.03
$11.43M
|
$5.167T | +45,210,489.55% | ||
|
$94,601.69
$11.43M
|
$5.015T | +43,878,236.98% | ||
|
$77,503.28
$11.43M
|
$4.108T | +35,947,616.06% | ||
|
$73,607.77
$11.43M
|
$3.902T | +34,140,794.84% | ||
|
$50,735.45
$11.43M
|
$2.689T | +23,532,114.43% |
